Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC) | Synapse
March 3, 2026Open Access
Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC)
Puntos clave
High-risk individuals benefit from risk-stratified surveillance approaches to detect neoplastic lesions early.
The risk-stratified group identified pancreatic lesions regardless of genetic predisposition status.
Assessment of individuals in the European Registry of Hereditary Pancreatic Diseases aids in understanding risk levels.
Potentially enhances early detection strategies for pancreatic cancer, improving patient outcomes.
Resumen
The risk-stratified group (FR) identifies neoplastic pancreatic lesion in individuals, regardless of PV status suggesting the key usefulness of this approach.